Sign In
Buy SYRE
Spyre Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -97.96. In total, the insiders bought 2.31M and sold 5.16M SYRE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-97.96 |
| ● Buy | 2.31M shares |
| ● Sell | 5.16M shares |
|
43% Buy Activity
Strong Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jul 01, 2026 Buy |
Burrows Scott L Chief Financial Officer |
7 500 Value: $108.8K |
||
|
Jul 01, 2026 Buy |
Burrows Scott L Chief Financial Officer |
7 500 Value: $108.8K |
||
|
Jul 01, 2026 Sell |
Burrows Scott L Chief Financial Officer |
5 775 Value: $505.6K |
||
|
Jul 01, 2026 Sell |
Burrows Scott L Chief Financial Officer |
1 725 Value: $152.4K |
||
|
Jul 01, 2026 Buy |
Sloan Sheldon Chief Medical Officer |
8 334 Value: $228.9K |
||
|
Jul 01, 2026 Buy |
Sloan Sheldon Chief Medical Officer |
8 334 Value: $228.9K |
||
|
Jul 01, 2026 Sell |
Sloan Sheldon Chief Medical Officer |
6 500 Value: $568.9K |
||
|
Jul 01, 2026 Sell |
Sloan Sheldon Chief Medical Officer |
1 834 Value: $162.0K |
||
|
Jul 01, 2026 Sell |
Turtle Cameron Chief Executive Officer |
10 176 Value: $889.8K |
||
|
Jul 01, 2026 Sell |
Turtle Cameron Chief Executive Officer |
4 234 Value: $373.1K |
||
|
Jul 01, 2026 Sell |
Turtle Cameron Chief Executive Officer |
590 Value: $52.5K |
||
|
Jun 25, 2026 Buy |
Burrows Scott L Chief Financial Officer |
15 000 Value: $217.5K |
||
|
Jun 25, 2026 Buy |
Burrows Scott L Chief Financial Officer |
15 000 Value: $217.5K |
||
|
Jun 25, 2026 Sell |
Burrows Scott L Chief Financial Officer |
5 000 Value: $435.6K |
||
|
Jun 25, 2026 Sell |
Burrows Scott L Chief Financial Officer |
10 000 Value: $871.4K |
||
|
Jun 23, 2026 Buy |
Fairmount Funds Management Llc Director |
666 680 Value: $64.7M |
||
|
Jun 23, 2026 Sell |
Fairmount Funds Management Llc Director |
4 684 781 Value: $0.40B |
||
|
Jun 23, 2026 Sell |
Fairmount Funds Management Llc Director |
16 667 Value: $0 |
||
|
Jun 22, 2026 Sell |
Henderson Michael Thomas Director |
20 000 Value: $2.00M |
||
|
Jun 03, 2026 Buy |
Sloan Sheldon Chief Medical Officer |
8 333 Value: $228.8K |
||
|
Jun 03, 2026 Buy |
Sloan Sheldon Chief Medical Officer |
8 333 Value: $228.8K |
||
|
Jun 03, 2026 Sell |
Sloan Sheldon Chief Medical Officer |
8 333 Value: $625.0K |
||
|
Jun 01, 2026 Sell |
Turtle Cameron Chief Executive Officer |
3 557 Value: $246.9K |
||
|
Jun 01, 2026 Sell |
Turtle Cameron Chief Executive Officer |
8 149 Value: $574.5K |
||
|
Jun 01, 2026 Sell |
Turtle Cameron Chief Executive Officer |
3 294 Value: $235.1K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
